Literature DB >> 31403710

LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation.

Keitaro Hayashi1, Osamu Kaminuma2,3,4, Tomoe Nishimura4, Mayumi Saeki4, Kunie Matsuoka5, Takachika Hiroi4, Promsuk Jutabha1, Yohei Iwata6, Kazumitsu Sugiura6, Takayoshi Owada7, Kazuhiro Kurasawa7, Isao Okayasu8, Motoshi Ouchi1, Tomoe Fujita1, Yoshikatsu Kanai9, Hitoshi Endou10, Naohiko Anzai1,11.   

Abstract

Entities:  

Keywords:  JPH203; L-type amino acid transporter 1; amino acid transporter; atopic dermatitis; immunosuppression

Year:  2019        PMID： 31403710     DOI： 10.1111/all.14019

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  3 in total

Review 1.  Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1.

Authors:  Keitaro Hayashi; Osamu Kaminuma
Journal:  Biomolecules       Date:  2022-04-08

2.  L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation.

Authors:  Daiki Ito; Kento Miura; Mayumi Saeki; Norimasa Yamasaki; Sawako Ogata; Teidai Koyama; Takachika Hiroi; Akio Mori; Hitoshi Endou; Keitaro Hayashi; Osamu Kaminuma
Journal:  Asia Pac Allergy       Date:  2021-07-19

Review 3.  Clinical development of metabolic inhibitors for oncology.

Authors:  Kathryn M Lemberg; Sadakatali S Gori; Takashi Tsukamoto; Rana Rais; Barbara S Slusher
Journal:  J Clin Invest       Date:  2022-01-04       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.